Schröder Christina, Buchali André, Windisch Paul, Vu Erwin, Basler Lucas, Zwahlen Daniel R, Förster Robert
Department of Radiation Oncology, Ruppiner Kliniken GmbH, Medizinische Hochschule Brandenburg (MHB), Fehrbelliner Strasse 38, 16816 Neuruppin, Germany.
Institute of Radiation Oncology, Cantonal Hospital Winterthur (KSW), Brauerstrasse 15, 8401 Winterthur, Switzerland.
Cancers (Basel). 2020 Dec 23;13(1):22. doi: 10.3390/cancers13010022.
To assess the impact of (low) dose irradiation to the lungs and heart on the incidence of pneumonitis and pulmonary function changes after thoracic radiotherapy (RT). Methods/Material: Data of 62 patients treated with curative thoracic radiotherapy were analyzed. Toxicity data and pulmonary function tests (PFTs) were obtained before RT and at 6 weeks, at 12 weeks, and at 6 months after RT. PFTs included ventilation (e.g., vital capacity) and diffusion parameters (e.g., diffusion capacity for carbon monoxide (DL)). Dosimetric data of the lung and heart were extracted to assess the impact of dose on PFT changes and radiation pneumonitis (RP).
No statistically significant correlations between dose parameters and changes in ventilation parameters were found. There were statistically significant correlations between DL and low-dose parameters of the lungs (V-V (%)) and irradiation of the heart during the follow-up up to 6 months after RT, as well as a temporary correlation of the V (%) on the blood gas parameters at 12 weeks after RT. On multivariate analysis, both heart and lung parameters had a significant impact on DL. There was no statistically significant influence of any patient or treatment-related (including dose parameters) factors on the incidence of ≥G2 pneumonitis.
There seems to be a lasting impact of low dose irradiation to the lung as well as irradiation to the heart on the DL after thoracic radiotherapy. No influence on RP was found in this analysis.
评估(低)剂量肺部和心脏照射对胸部放疗(RT)后肺炎发生率和肺功能变化的影响。方法/材料:分析62例接受根治性胸部放疗患者的数据。在放疗前、放疗后6周、12周和6个月时获取毒性数据和肺功能测试(PFT)结果。PFT包括通气功能(如肺活量)和弥散参数(如一氧化碳弥散量(DL))。提取肺部和心脏的剂量学数据,以评估剂量对PFT变化和放射性肺炎(RP)的影响。
未发现剂量参数与通气参数变化之间存在统计学显著相关性。在放疗后长达6个月的随访期间,DL与肺部低剂量参数(V-V(%))以及心脏照射之间存在统计学显著相关性,并且在放疗后12周时V(%)与血气参数存在暂时相关性。多因素分析显示,心脏和肺部参数均对DL有显著影响。任何患者或治疗相关(包括剂量参数)因素对≥G2级肺炎的发生率均无统计学显著影响。
胸部放疗后,低剂量肺部照射以及心脏照射似乎对DL有持久影响。本分析未发现对RP有影响。